期刊文献+

MMP2、TIMP2在子宫颈鳞癌中的表达及其意义 被引量:2

Expression of MMP2 and TIMP2 in Squamous Cell Carcinoma of Uterine Cervix and Its Clinical Significance
下载PDF
导出
摘要 【目的】探讨MMP2、TIMP2在子宫颈鳞癌组织的表达及其意义。【方法】采用免疫组织化学S P法 ,分别检测 4 5例子宫颈鳞癌组织、30例宫颈上皮内瘤样病变 (cervicalintraepithelialneoplasia ,CIN)和 14例正常宫颈组织中MMP2、TIMP2的表达情况。【结果】MMP2、TIMP2在子宫颈鳞癌、CIN、正常宫颈组织中的阳性表达率分别为 82 .2 %、80 .0 % ;4 3.3%、5 0 .0 % ;2 1.4 %、35 .7%。鳞癌组的MMP2表达与CIN组及正常组相比差异有显著性 (P <0 .0 1)。TIMP2的鳞癌组与CIN组及正常组相比差异有显著性意义 (P <0 .0 1)。MMP2的阳性表达率与患者 3年生存期呈密切相关 (P <0 .0 5 )。MMP2、TIMP2的表达与肿瘤大小、临床分期及病理分级均无明显相关性。【结论】MMP2、TIMP2的过度表达与子宫颈癌的发展有密切关系 ,可作为临床预测其预后的重要指标。 To study the expression of matrix metalloproteinaxe-2(MMP2) and tissue inhibitor of metalloproteinase-2(TIMP2) in squamous cell carcinoma of uterine cervix. (SCUC) and its significance.The expressions of MMP2 and TIMP in 45 cases with SCUC, 30 cases of cervical intraepithelial neoplasia (CIN) and 14 cases of normal cervices were detected by immunohistochemical S-P method.The positive expression rates of MMP2 and TIMP2 in SCUC, CIN and normal cervices were 82.2%, 80.0% ; 43.3%, 50.0% and 21.4%, 35.7% , respectively. There were significant differences in MMP2 among SCUC group and CIN / normal groups (P<0.01). Obvious differences in TIMP2 also existed among SCUC group and CIN/normal groups (P<0.01). The positive expression rate of MMP2 was closely correlated with 3-year survival period of SCUC patients (P<0.05) ; while no remarkable correlations could be found among the expression of MMP2 / TIMP2 and the size, clinical stage and pathologic grade of tumors.[Conclusion]Over expression of MMP2 and TIMP2 is closely correlated to the progression of uterine cervical carcinoma. It can be used as an important index for clinical predict ion of patient prognosis.
出处 《医学临床研究》 CAS 2004年第6期637-639,共3页 Journal of Clinical Research
关键词 宫颈肿瘤/病理学 鳞状细胞/病理学 cervix neoplamsms/PA carcinoma,squamous cell/PA
  • 相关文献

参考文献8

  • 1Chamber AF, Matrisian LM. Changing views of matrix metal loproteinase in metastasis[J]. Natl Cancer Inst , 1997, 89:1201-1265.
  • 2Lamper K, Machein U, Machein MR, et al. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors[J]. Am J Pathot , 1998, 153:429-432.
  • 3Thomas P, Khokha R, Shepherd FA, et al . Differential expression of MMPs and their inhibitors in non-small cell lung cancer[J]. J Pathol , 2000, 190(2):150-156.
  • 4Stephanie C, Graeme I. Matrix metalloproteinase expression in tumor invasion and metastasis[J]. J Pathol , 1999,189(3):300-308.
  • 5Delebecq TJ, Porte H, Zerimech F, et al . Overexpression lev el of stomelysins is related to lymph node involvemeat in nonsmall cell lung cancer[J]. Clin Cancer Res , 2000,6(3):1086-1092.
  • 6Davidson B, Goldberg I, Kopolovic, et al . MMP2 and TIMP2expression correlates with poor prognosis in cervical carcinoma clinicopathologic study using immunohistochemistry and mRNA in situ hybridization[J]. Gynecol Oncol , 1999, 73 (3): 372-382.
  • 7Talvensanri A, Apaia-sarkinen M, Hoyhtya M, et al . Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation[J]. Gryneeol Oncol , 1999,72(3):306-311.
  • 8Gomez DE, Alonso DF, Yoshiji H, et al . Tissue inhibitor of metalloproteinases: structure, regulation and histological functions[J]. Eur J Cell Biol , 1997,74(1): 111-122.

同被引文献16

  • 1赵海,于志丹.基质金属蛋白酶抑制剂与胃癌浸润转移的关系[J].实用临床医学(江西),2005,6(2):4-6. 被引量:4
  • 2田东波,肖伟民,曾峰,潘桂常.非小细胞肺癌组织中MMP2及TIMP2的表达与转移、预后相关性研究[J].实用临床医学(江西),2005,6(1):4-7. 被引量:2
  • 3陆健,卞建民.S100A4蛋白与肿瘤转移和侵袭的研究进展[J].国外医学(外科学分册),2005,32(6):454-458. 被引量:4
  • 4Murray GI.Matrix metaloproteinases:a multifunctionalgroup of molecules.J Pathol,2001,195(2):135-137.
  • 5Loukopoulos P,Mungall BA,Straw RC,et al.Matrix metaloproteinases-2 and -9 involvement in canine tumors.Vet Pathol,2003,40(4):382-394.
  • 6GAO X N, TANG S Q, ZHANG X F. S100A4 antisense oli- godeoxynucleotide suppresses invasive potential of neuroblas- toma cells [J]. J Pediatr Surg, 2005,40(4):648-652.
  • 7ZHANG S, WANG G Z, FERNIG D G, et al. Interaction of metastasis-inducing S100A4 protein in vivo by fluorescence li- fetime imaging microscopy[J]. Eur Biophys J, 2005,34 (1) : 19-27.
  • 8EL NAAMAN C, GRUM-SCHWENSEN B, MANSOURI A, et al. Cancer predisposition in mice deficient for the metasta- sis-associated Mtsl (S100A4) gene[J]. Oncogene, 2004, 23 (20) :3670-3680.
  • 9AMBARTSUMIAN N, KLINGELHOFER J, GRIGORIAN M, et al. The metastasis-associated Mts1(S100A4) protein could act as an antigenic factor [J]. Oncogene, 2001,20(34) : 4685-4695.
  • 10STEIN U, ARLT F, WALTHER W, et al. The metastasis associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer[J]. Gastroenterology, 2006, 131 (5) : 1486-1500.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部